Talk:Cosyntropin

This is the talk page for discussing improvements to the Cosyntropin redirect.
This is not a forum for general discussion of the article's subject.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Pharmacology Mid‑importance

	This redirect is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Mid	This redirect has been rated as Mid-importance on the project's importance scale.

Chemicals Mid‑importance

	This redirect is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this redirect or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals
Mid	This redirect has been rated as Mid-importance on the project's importance scale.

	This redirect is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology
	This redirect is supported by the Molecular and Cell Biology task force (assessed as Mid-importance).

Untitled

Need to rule out central adrenal insufficiency before treating central hypothyroidism. Why? Tetracosactin and cosyntropin are ACTH(1-24) — Preceding unsigned comment added by Farmacol (talk • contribs) 14:06, 10 October 2011 (UTC)[reply]